Lok Sze Ho

750 citations
13 papers · 610 indexed · h-index 10
Topics
Cystic Fibrosis Research Advances (4 papers)Neonatal Respiratory Health Research (3 papers)Signaling Pathways in Disease (2 papers)

In The Last Decade

Lok Sze Ho

13 papers receiving 599 citations

Peers

Lok Sze Ho
Comparison fields: 5 of 73
  • Molecular Biology 303
  • Immunology 196
  • Reproductive Medicine 187
  • Microbiology 115
  • Public Health, Environmental and Occupational Health 99
Replace Perumal Sivashanmugam with:
Perumal Sivashanmugam United States
Caroline Osterhoff Germany
Murli Manohar United States
A. Lefèvre France
Inju Park South Korea
Élaine Beaulieu Australia
Kyoko Kasahara Japan
Liqing Xiao United States
Jodi E. Goldberg United States
Patricia V. Basta United States
Lok Sze Ho relative to Perumal Sivashanmugam United States Perumal Sivashanmugam's profile →
Citations per field
00.5×3.2×
Perumal Sivashanmugam · 1×
Citations per year

Countries citing papers authored by Lok Sze Ho

Since Specialization
Citations

This map shows the geographic impact of Lok Sze Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lok Sze Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lok Sze Ho more than expected).

Fields of papers citing papers by Lok Sze Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lok Sze Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lok Sze Ho. The network helps show where Lok Sze Ho may publish in the future.

Co-authorship network of co-authors of Lok Sze Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Lok Sze Ho. A scholar is included among the top collaborators of Lok Sze Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lok Sze Ho. Lok Sze Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 5
2 14
3 10
4 7
5 9
6 14
7 26
8 23
9 46
10 43
11 207
12 97
13 109

About Lok Sze Ho

Lok Sze Ho is a scholar working on Reproductive Medicine, Immunology and Microbiology, having authored 13 papers that have together received 610 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (4 papers), Neonatal Respiratory Health Research (3 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Reproductive Medicine (187 citations), Microbiology (115 citations) and Immunology (196 citations). Lok Sze Ho has collaborated with scholars based in Hong Kong, China and United Kingdom. Frequent co-authors include Yiu Wa Chung, Lai Ling Tsang, Hsiao Chang Chan, Chen Zhou, Mei Yu, Hsiao Chang Chan, Ka Man Leung, Louis Chukwuemeka Ajonuma, Qing Zhou and Zhi‐Nan Chen. Their work appears in journals such as Journal of Biological Chemistry, Nature Cell Biology and Cellular and Molecular Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026